NASDAQ:AMED
Amedisys Inc Stock News
$90.96
-0.290 (-0.318%)
At Close: Apr 17, 2024
Amedisys (AMED) Q1 Earnings Beat Estimates, Margins Dip
02:26pm, Thursday, 04'th May 2023
Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.
Amedisys (AMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
10:47pm, Wednesday, 03'rd May 2023
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare
Amedisys (AMED) New Buyouts Aid Growth, CMS Ruling Unfavorable
12:09pm, Friday, 14'th Apr 2023
For Amedisys (AMED), dealing with the continuous shortage of clinical labo, in nursing in particular, has been challenging.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
09:55am, Tuesday, 04'th Apr 2023
Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.
Amedisys to Present at Multiple Healthcare Conferences in March
07:30am, Thursday, 09'th Mar 2023
BATON ROUGE, La., March 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul Kusserow,
Amedisys (AMED) Q4 Earnings Beat, Operating Margin Dips
09:47am, Friday, 17'th Feb 2023
Amedisys (AMED) delivers strong Home Health performance in the fourth quarter amid cost pressure.
Amedisys, Inc. (AMED) Q4 2022 Earnings Call Transcript
04:28pm, Thursday, 16'th Feb 2023
Amedisys, Inc. (NASDAQ:AMED ) Q4 2022 Earnings Conference Call February 16, 2023 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Paul Kusserow - Chairman & CEO Scott Ginn - EVP,
Amedisys (AMED) Surpasses Q4 Earnings and Revenue Estimates
07:34pm, Wednesday, 15'th Feb 2023
Amedisys (AMED) delivered earnings and revenue surprises of 12.62% and 0.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Dates
08:00am, Monday, 30'th Jan 2023
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the f
Amedisys (AMED) Faces Macro Challenges, Margin Pressure
01:32pm, Thursday, 05'th Jan 2023
The Contessa Health acquisition seems to be strategically aligned with Amedisys' (AMED) business.
Amedisys to Present at the 41st Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 28'th Dec 2022
BATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow
Amedisys to Present at Bank of America Securities Home Care Conference
05:30pm, Friday, 02'nd Dec 2022
BATON ROUGE, La., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow
Amedisys: No Change To Thesis, Retain Hold
04:36am, Wednesday, 23'rd Nov 2022
Company CEO departed last week, although management reaffirmed FY22 guidance. Speaking of guidance, growth at the top–bottom lines was narrowed down on the Q3 earnings call.
Amedisys (AMED) Q3 Earnings Miss Estimates, Guidance Cut
01:34pm, Monday, 31'st Oct 2022
Within Amedisys (AMED) Home Health and Hospice, the reinstatement of sequestration reduces growth in Q3.
Amedisys, Inc. (AMED) Q3 2022 Earnings Call Transcript
05:42pm, Thursday, 27'th Oct 2022
Amedisys, Inc. (NASDAQ:AMED ) Q3 2022 Earnings Conference Call October 27, 2022 11:00 AM ET Company Participants Nick Muscato – Chief Strategy Officer Chris Gerard – President and Chief Executive
